Background. Information on molecular targets that may be involved in the neurotoxicity of bupivacaine is limited. Suppression of Kv3 channels has been demonstrated to result in abnormal patterns in the electroencephalogram and in seizures. Inhibition of Kv3 channels by bupivacaine may consequently contribute to its neuroexcitatory side-effects. Data on the effects of bupivacaine on these potassium channels are lacking. We therefore characterized the effects of bupivacaine on human Kv3 channels natively expressed in SH-SY5Y cells.
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Excitatory actions in the human nervous system are wellknown side-effects of local anaesthetic agents. 1 These sideeffects may occur in up to one in 145 patients during regional anaesthesia. 1 Seizures induced by local anaesthetics may be accompanied by cardiovascular changes, acidosis and severe hypoxia. 2 Information on the anaesthetic targets that may be involved in these neurotoxic effects is limited. Recent molecular evidence emphasizes the importance of human voltage-dependent potassium channels in the pathogenesis of epileptic disorders. 3 Mutations in the genes encoding voltage-dependent potassium channels of the Kv and KCNQ channel families cause seizures in animal and man through a decrease in neuronal potassium currents. 3 Local anaesthetic-induced potassium current suppression may thus contribute signi®cantly to the excitatory side-effects of these anaesthetic agents.
The aim of this study was to characterize the effects of bupivacaine on human neuronal Kv3 channels. Kv3 channels are crucial for spike frequency adaptation in central neurones. 4 Evidence from knockout mice demonstrates that suppression of Kv3 channels causes impaired motor skill, muscle contraction, abnormal EEG patterns and epileptic seizures. 4 Inhibition of human Kv3 channels by bupivacaine may contribute to the neuronal excitation and epileptic seizures observed during accidental intravascular application of this drug.
Methods and results
Voltage-sensitive outward currents in SH-SY5Y cells 5 were recorded with the whole-cell patch-clamp technique 6 at room temperature (22±25°C) with an EPC-7 ampli®er (List Electronic, Darmstadt, Germany) and pClamp software version 5.71 (Axon Instruments, Foster City, CA, USA) as described previously. 7 The peak outward potassium current in a trace was determined by ®tting the current to a twoexponential time course (activation and inactivation) and determining the maximal amplitude of the ®t. Peak currents were converted to conductances using the Nernst potential for potassium and the voltage was corrected using the measured series resistance and compensation level. The conductance±voltage data were ®tted to a Boltzmann function. Inhibition (b) was de®ned as 1 minus the ratio of the maximal potassium conductance (G max ) in the presence of the drug to the mean of the current before and after application of the drug. Changes in activation midpoint (V mid ) were quanti®ed as the difference between V mid in the presence of the drug and the mean of V mid before and after application of the drug. Concentration±response curves were ®tted with the Hill equation. Data are given as mean (standard deviation) for n experiments unless stated otherwise. Statistical comparison was performed with the unpaired Student's t-test.
Bupivacaine reversibly inhibited human Kv3 potassium channels. The potassium current traces in Figure 1 demonstrate the inhibitory effect. Bupivacaine accelerated macroscopic current decline (Fig. 1) by inducing inactivation-like behaviour. In the presence of bupivacaine, the potassium currents declined more than 100±150 times faster at potentials between +40 and +70 mV compared with potassium currents in the absence of the local anaesthetic. The time constants of this inactivation-like behaviour did not differ between test potentials of +40 and +70 mV. The time constants depended on concentration [4.4 (1.5) and 2.9 (1.2) ms at 10 and 100 mM respectively; P<0.05, n=8±10].
The effect of the local anaesthetic on these potassium channels was measured as inhibition of the maximal wholecell conductance (G max ; for details, see above). Under control conditions, G max was 7.5 (1.8) nS (n=60). Inhibition of G max was concentration-dependent and reversible (Fig. 1) . It was described mathematically by Hill functions. The halfmaximal inhibitory concentration (IC 50 ) for inhibition of G max by bupivacaine was 57 mM. The Hill coef®cient was 0.7 (n=60). The membrane potential at which half the channels were activated (V mid ) was shifted by bupivacaine in the depolarizing direction. The reversible shift was concentration-dependent and had a maximum value of 26 mV. The IC 50 for the shift was 47 mM and the Hill coef®cient was 2.4 (n=60).
Comment
The local anaesthetic agent bupivacaine reversibly inhibited human neuronal Kv3 channels in a concentration-dependent manner. The midpoint of current activation was shifted to more depolarized potentials by the local anaesthetic. Both drug effects would be compatible with a contributory role of Kv channel inhibition in bupivacaine-induced convulsion. 8 Human Kv3 channels belong to a superfamily of voltagedependent potassium channels consisting of six transmembrane domains. 3 4 Mutations of several members of this potassium channel superfamily cause inherited forms of human epilepsy by suppression of neuronal potassium channel activity.
3 Kv3 knockout mice exhibit abnormal neuronal behaviour ranging from impaired motor skill to abnormal EEG patterns and epileptic seizures. 4 Estimates based on in vitro and animal experiments suggest that Inhibition of human Kv3 channels by bupivacaine inhibition of voltage-dependent potassium channels by 25±50% may cause epilepsy. 3 As calculated from the Hill equation, the inhibition produced by the free plasma concentrations of bupivacaine that are estimated to cause seizure in man (35 mM) 9 and dogs (32±126 mM) 10 would suppress the Kv3 channels by at least 40%. The observed inhibition of human Kv3 channels by bupivacaine would thus be suf®cient to account for excitatory side-effects.
The depolarizing shift of the activation threshold by 10±20 mV induced by bupivacaine would add to the possible increase in neuronal excitability induced by inhibition of the potassium channel conductance. 8 Both a 50% channel block and a 15 mV depolarizing shift would alone induce spontaneous ®ring of the Hodgkin±Huxley squid axon model. 8 In the presence of a 15 mV depolarizing shift in potassium channel activation, spontaneous ®ring of the axon would persist if 90% of the sodium channels were blocked. 8 The combination of potassium channel inhibition and a depolarizing shift in the activation threshold, as observed in our study, would be compatible with neuronal excitation during bupivacaine intoxication. Establishing structural requirements for local anaesthetic action on human neuronal Kv channels may therefore help to elucidate the molecular determinants of the convulsive side-effects of this drug.
